Abstract:Abstract Background Cancer is caused by a combination of genetic and epigenetic abnormalities. Current cancer therapies are limited due to the complexity of their mechanism, underlining the need for alternative therapeutic approaches. Interestingly, combining the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR/Cas9) system with next-generation sequencing (NGS) has the potential to speed up the identification, validation, and targeting of high-value targets. Main text Personalized or precision medicine combines genetic information with phenotypic and environmental characteristics to produce healthcare tailored to the individual and eliminates the constraints of “one-size-fits-all” therapy. Precision medicine is now possible thanks to cancer genome sequencing. Having advantages over limited sample requirements and the recent development of biomarkers have made the use of NGS a major leap in personalized medicine. Tumor and cell-free DNA profiling using NGS, proteome and RNA analyses, and a better understanding of immunological systems, are all helping to improve cancer treatment choices. Finally, direct targeting of tumor genes in cancer cells with CRISPR/Cas9 may be achievable, allowing for eliminating genetic changes that lead to tumor growth and metastatic capability. Conclusion With NGS and CRISPR/Cas9, the goal is no longer to match the treatment for the diagnosed tumor but rather to build a treatment method that fits the tumor exactly. Hence, in this review, we have discussed the potential role of CRISPR/Cas9 and NGS in advancing personalized medicine.

Synthetic biology and personalized cancer therapy

Recent development on synthetic biological devices treating bladder cancer

Applications of synthetic biology in medical and pharmaceutical fields

Synthetic biology approaches for improving the specificity and efficacy of cancer immunotherapy

Synthetic biology-inspired cell engineering in diagnosis, treatment, and drug development

Personalized Cancer Therapy Using a Patient-Derived Tumor Tissue Xenograft Model: a Translational Field Worthy of Exploring Further?

Synthetic Biology for Therapeutic Applications

Personalized And Dynamic Therapy For Gastric Cancer: A Perspective

Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer

Clinical cancer genomics and personalized treatment

[Whole-genome sequencing: a new approach for understanding of pathogenesis and individualized treatment of cancer].

CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer

Application of Genome Engineering in Medical Synthetic Biology

Application of Synthetic Biology to Bladder Cancer Treatment

Synthetic Lethality in Personalized Cancer Therapy

[Smart Therapeutics Based on Synthetic Gene Circuits].

Personalized Precision Diagnosis and Therapy：Development and Challenge in Clinic

Application of precision medicine based on synthetic biology in the prevention and treatment of chronic diseases

The Current Status and Future Perspective of Personalized and Precise Medicine in Cancer

Individualized Cancer Therapy, Future Approaches

Review of Personalized Medicine and Pharmacogenomics of Anti-Cancer Compounds and Natural Products